Your browser doesn't support javascript.
loading
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity.
Mankelow, Tosti J; Blair, Allison; Arnold, David T; Hamilton, Fergus W; Gillespie, Kathleen M; Anstee, David J; Toye, Ashley M.
Afiliação
  • Mankelow TJ; Bristol Institute for Transfusion Sciences, NHSBT, Bristol, UK.
  • Blair A; NIHR Blood and Transplant Research Unit in Red Cell Products, University of Bristol, Bristol, UK.
  • Arnold DT; Bristol Institute for Transfusion Sciences, NHSBT, Bristol, UK.
  • Hamilton FW; NIHR Blood and Transplant Research Unit in Red Cell Products, University of Bristol, Bristol, UK.
  • Gillespie KM; Infection Sciences, Southmead Hospital North Bristol NHS Trust, Bristol, UK.
  • Anstee DJ; Infection Sciences, Southmead Hospital North Bristol NHS Trust, Bristol, UK.
  • Toye AM; Population Health Sciences, University of Bristol, Bristol, UK.
Transfus Med ; 32(3): 261-262, 2022 06.
Article em En | MEDLINE | ID: mdl-35332587
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article